Search results
Results from the WOW.Com Content Network
COVID-19 vaccines are considered safe and effective by the FDA. Adverse reactions to the shots are possible, but rare, according to the Centers for Disease Control and Prevention.
Nature, 2024, Myocarditis associated with COVID-19 vaccination. MedrXiv, May 20, OpenSAFELY: Effectiveness of COVID-19 vaccination in children and adolescents. Thank you for supporting our journalism.
Rare instances of vaccine side-effects must not be used to “undermine the vital public health role that vaccination plays in keeping people safe from disease”, the UK Covid-19 Inquiry has heard.
A 2022 meta-analysis on COVID-19 vaccines and pregnancy found that pregnant people were less likely to get vaccinations compared with non-pregnant cohorts. Factors associated with lower takeup of vaccination during pregnancy included younger age, lower education, lower socioeconomic status , and lack of adherence to influenza vaccination ...
Vaccination against COVID-19 was not associated with an increase in miscarriage or reduction in live birth. [21] Meta-analysis has not identified any pregnancy-specific safety concerns with vaccines. [22] The data overwhelming support maternal vaccination as being effective at reducing the risk for infection and severe illness. [22]
Because cases of thrombosis with thrombocytopenia syndrome and Guillain-Barré syndrome have been reported after receipt of the Janssen COVID‑19 vaccine, the US Centers for Disease Control and Prevention (CDC) recommends "preferential use of mRNA COVID‑19 vaccines over the Janssen COVID‑19 vaccine, including both primary and booster doses ...
The most recent COVID-19 vaccine should offer protection against the XEC variant, Russo says. “The most recent version of the vaccine seems to be reasonably well-matched,” he says.
In general, misinformation related to the COVID-19 vaccine reduced public confidence. Public acceptance of Chinese domestic COVID-19 vaccines dropped significantly due to concerns about the possible high cost. An online survey in China showed only 28.7% of the participants expressed definite interest in getting the vaccine.